• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

    33.25 -0.13 (-0.39%)
    Streaming Delayed Price Updated: 2:51 PM EDT, Jun 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 102,902
    Open 33.46
    Bid (Size) 33.25 (300)
    Ask (Size) 33.31 (100)
    Prev. Close 33.38
    Today's Range 33.22 - 33.59
    52wk Range 29.08 - 50.79
    Shares Outstanding 32,250,236
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    2 Reasons to Sell COLL and 1 Stock to Buy Instead
    Shareholders of Collegium Pharmaceutical would probably like to forget the past six months even happened. The stock dropped 36.3% and now trades at $30.47. T... 
    Via StockStory
    Topics Supply Chain

    Performance

    YTD
    -27.0%
    -27.0%
    1 Month
    -12.0%
    -12.0%
    3 Month
    -10.8%
    -10.8%
    6 Month
    -30.6%
    -30.6%
    1 Year
    +9.2%
    +9.2%

    More News

    Read More
    News headline image
    Collegium to Participate in 2026 Jefferies Global Healthcare Conference
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    3 Growth Stocks We’re Skeptical Of
    Via StockStory
    Collegium Pharmaceutical (NASDAQ:COLL) Surges on Q1 Earnings Beat as JORNAY PM Revenue Jumps 36% ↗
    Via Chartmill
    Topics Earnings
    Collegium Pharmaceutical Inc (NASDAQ:COLL) Priced for a Value Rebound ↗
    Via Chartmill
    Collegium Pharmaceutical Inc (NASDAQ:COLL) Presents a Compelling Value Investment Case ↗
    Via Chartmill
    News headline image
    Collegium Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions
    Via StockStory
    Topics Earnings
    News headline image
    Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    1 Healthcare Stock with Competitive Advantages and 2 We Brush Off
    Via StockStory
    News headline image
    COLL Q1 Deep Dive: ADHD Portfolio Expansion and Pain Segment Stability Drive Results
    Via StockStory
    News headline image
    Collegium (COLL) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q1 CY2026 Expectations, Stock Soars
    Via StockStory
    News headline image
    Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Collegium Pharmaceutical (COLL) Q1 Earnings Report Preview: What To Look For
    Via StockStory
    News headline image
    1 Small-Cap Stock on Our Watchlist and 2 We Question
    Via StockStory
    News headline image
    3 Reasons to Sell COLL and 1 Stock to Buy Instead
    Via StockStory
    Topics Stocks Supply Chain
    News headline image
    Collegium to Report First Quarter 2026 Financial Results on May 7, 2026
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
    Via StockStory
    News headline image
    3 Cash-Producing Stocks Walking a Fine Line
    Via StockStory
    News headline image
    1 Value Stock on Our Buy List and 2 Facing Headwinds
    Via StockStory
    Topics ETFs
    News headline image
    GE HealthCare and Collegium Pharmaceutical Stocks Trade Down, What You Need To Know
    Via StockStory
    Topics Economy Stocks World Trade
    News headline image
    2 Profitable Stocks to Consider Right Now and 1 We Question
    Via StockStory
    Topics Bonds
    News headline image
    Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD ↗
    Via The Motley Fool
    Topics Regulatory Compliance

    Frequently Asked Questions

    Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?
    Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.
    What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?
    Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?
    The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market
    What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?
    The current price of Collegium Pharmaceutical, Inc. - Common Stock is 33.25
    When was Collegium Pharmaceutical, Inc. - Common Stock last traded?
    The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 06/08/26 02:51 PM ET
    What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?
    The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 1.07B
    How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?
    Collegium Pharmaceutical, Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.